Clinical Trial Update: Eprotirome for the Treatment of Dyslipidemia, Efficacy and Safety 12-Week, Phase ii Study to Assess the Safety and Efficacy of KB2115 in Patients With Primary Hypercholesterolemia [Phase 2]

View source ↗

Summary

This clinical trial update reports the completion of a 12-week Phase II study evaluating the safety and efficacy of KB2115 (eprotirome) in patients with primary…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hypercholesterolemia

Drugs mentioned

• Eprotirome (eprotirome)

Snippet

Sponsor: Karo Bio AB | Conditions: Primary Hypercholesterolemia | Phase 2 | Status: COMPLETED